Serum samples were collected at slaughter from 226 24-30-month-old ranch-raised, clinically normal American bison (Bison bison) bulls from North Dakota, Minnesota, Kansas, and Manitoba to assess the presence of antibodies to ovine herpesvirus 2 (OHV-2). Antibodies to OHV-2 were detected by competitive inhibition enzyme-linked immunosorbent assay in 10 of 226 (4.40%) samples. Polymerase chain reaction (PCR) analysis of sera positive for OHV-2 DNA demonstrated a 238 kilobase fragment. The nucleotide sequence of the PCR-positive samples in comparison to the reported OHV-2 nucleotide sequence resulted in a homology range of 82.8-95.4%.
Malignant catarrhal fever (MCF), an often fatal gammaherpesvirus infection of wild and domestic ruminants worldwide, exists as 2 epidemiologic entities: wildebeest-associated MCF (WA-MCF) and sheep-associated MCF (SA-MCF). WA-MCF, endemic in the wildebeest population, is known to be caused by alcelaphine herpesvirus 1, and SA-MCF is believed to be caused by ovine herpesvirus 2 (OHV-2). This identification of OHV-2 as the putative agent of SA-MCF is due to a large body of evidence identifying OHV-2 DNA in animals clinically affected with SA-MCF and in noninfected sheep. [1] [2] [3] 5 Domestic sheep are thought to be the reservoir for SA-MCF and may transmit the disease to susceptible ruminants such as the American bison (Bison bison). [1] [2] [3] [4] [5] [6] MCF has a sporadic incidence, with high mortality, and is characterized by a wide variety of clinical signs in bison ranging from sudden death to epithelial erosions, corneal opacity, and oculonasal discharge. 6, 8, 9, 12 Typical microscopic lesions include lymphocytic vasculitis, epithelial necrosis, and lymphoproliferation. 6, 8, 11 Recent studies have shown that MCF can cause chronic disease and a pansystemic proliferative arteriopathy in bison. 11 Previous work indicates that a low percentage of bison (0-9%) are seropositive to SA-MCF but are clinically normal. 5 Similarly, 4.4% of the serum samples from bison in this study were seropositive for OHV-2. There is a high correlation for the diagnosis of OHV-2 between polymerase chain reaction (PCR) assays and the competitive inhibition enzyme-linked immunosorbent assay (CI-ELISA). In a comparison study, 94% of samples were positive with CI-ELISA and 99% were positive by PCR assay. 6 OHV-2-specific PCR analysis amplifies a band composed of a 238-base pair (bp) fragment of a 140-kD tegument protein from peripheral blood lymphocyte DNA of sheep, cattle, deer, bison, and other ruminants with OHV-2. 6 With these tools, the accuracy of the diagnosis of OHV-2 has been considerably improved.
This study was designed to accomplish 2 goals: 1) use PCR analysis to demonstrate OHV-2 DNA in bison serum samples positive for antibody to OHV-2 by CI-ELISA and 2) compare OHV-2 nucleotide sequences from American bison to the reported OHV-2 nucleotide sequence.
Materials and methods
Serum samples. Blood samples were collected from 226 24-30-mo-old clinically normal American bison bulls from North Dakota, Minnesota, Kansas, and Manitoba at the North Dakota Bison Cooperative (New Rockford, ND). Samples were centrifuged, and the serum was separated 12 hr after collection.
DNA isolation. DNA was extracted from each serum sample using 2 different methods for use in PCR analysis. Serum was initially digested with 20 mg/ml proteinase K a at 50 C for 1 hr. DNA was extracted with phenol-chloroform-isoamyl alcohol and precipitated with ethanol overnight at Ϫ20 C. DNA was suspended in a Tris-ethylenediaminetetracetic acid (EDTA) buffer or water and quantified by ultraviolet (UV) spectrophotometry.
Serum samples also were processed for the release of genomic DNA using GeneReleaser b according to the manufacturer's instructions.
PCR. PCR was performed on 10 OHV-2 CI-ELISA-positive bison serum samples, 10 OHV-2-negative bison serum samples, and 1 sheep serum sample. Because the goal was to demonstrate OHV-2 DNA in CI-ELISA-positive field samples (10), a matching number of CI-ELISA-negative samples was also used.
Primers. All primers used in PCRs for the detection of OHV-2 viral DNA were from the published OHV-2 se- (Table 1 ). Primer pair 556 c /775 c was used in the first PCR amplification step and was predicted to result in a 422bp fragment. Primer pair 556 c /555 c was used in the second step and was predicted to result in a 238-bp fragment.
Amplification of DNA. All amplification reactions were performed in a 50-l volume containing 10 mM Taq buffer The PCR products from the first step (10 l) were used as targets for amplification in the second step.
PCR product identification. The amplified PCR products were detected by agarose gel electrophoresis. A sample of the total reaction (0.1 volume) was loaded onto a 2% agarose gel containing ethidium bromide (0.5 g/ml) and visualized under UV light. A 1-kilobase DNA ladder was included on all gels for size comparisons.
DNA blots. The amplified PCR products were transferred onto a nylon membrane and analyzed by Southern hybridization. The PCR products were transferred onto a 0.45-m pore size nylon membrane f using a blotting apparatus. g After transfer, the DNA was fixed to the membrane by baking at 80 C for 1 hr in a vacuum oven.
Radioactive labeling of primers. An oligonucleotide was radiolabeled and used as a probe to detect the target DNA immobilized on the nylon membranes. Primer 555 was 5Јend labeled as previously described. 10 Prehybridization and hybridization. All membranes were prehybridized at 50 C for 2.5 hr in 7% sodium dodecyl sulfate (SDS), 0.5 M NaHPO 4 , and 1 mM EDTA. The hybridization reaction was carried out at 50 C for 18 hr in 7% SDS, 0.5 M NaHPO 4 , 1 mM EDTA, and 1.0-2.0 ϫ 10 7 cpm radioactively labeled probe. After hybridization, the blots were washed as follows: 3 times in 6ϫ Standard Saline Citrate (SSC)/0.1% SDS at room temperature for 5 min, twice in 3ϫ SSC/0.1% SDS at 50 C for 30 min, and twice in 1ϫ SSC/0.1% SDS at 50 C for 20 min. The moist blots were sealed in hybridization bags and autoradiographed.
Autoradiography. All membranes were exposed to x-ray film h at room temperature for 48-72 hr.
Cloning. Amplified fragments of 238 bp from each sample were cloned into the EcoRI site of pCR2.1 i according to the manufacturer's instructions. The 11 clones used in this study each had an insert of approximately 238 bp.
Clone verification and characterization. Small-scale plasmid preparations were made of those colonies thought to contain an insert. The selected colonies were placed in LB medium (1.0% Bacto-tryptone, 0.5% Bacto-yeast extract, 1.0% NaCl, pH 7.0) with 50 g/ml ampicillin and shaken at 37 C overnight. The cells were pelleted by centrifugation at 2,180 ϫ g for 6 min. at room temperature. The supernatant solution was discarded, and the pellet was suspended in cold lysozyme (4 mg/ml lysozyme in 50 mM glucose, 10 mM EDTA, and 25 mM Tris-HCl buffer) and incubated at room temperature for 5 min. This solution was followed by the addition of NaOH-SDS (20% SDS, sterile water, 1 M NaOH). The contents were mixed by inverting the tube 3 times, 5 M sodium acetate was added, and the tube was placed on ice for 5 min.
The sample was clarified by centrifugation j at 2,180 ϫ g for 6 min at room temperature. The supernatant solution was transferred to a sterile microcentrifuge tube, 1% RNase was added, and the sample was incubated for 30 min at room temperature. The DNA was extracted by the addition of phenol : chloroform (1:1); the sample was clarified by centrifugation at 2,180 ϫ g for 6 min at room temperature, and the upper aqueous phase was transferred to a fresh microcentrifuge tube. The plasmid DNA was precipitated by adding 2 volumes of absolute ethanol and incubating overnight at Ϫ20 C. The plasmid DNA was pelleted by centrifugation at 2,180 ϫ g for 20 min at room temperature, the supernatant was removed, and the pellet was washed with cold 70% ethanol. The pellet was dried at room temperature for 30 min, redissolved in Tris-EDTA buffer (pH 8.0), and stored at Ϫ20 C.
Endonuclease restriction digestion. The 11 purified plasmid preparations that resulted were linearized by restriction endonuclease EcoRI d digestion. The restriction digestion reaction was performed in a 20 l solution containing sterile water, 10 l of the DNA preparation (0.5-2.0 g/l), EcoRI restriction buffer, and EcoRI. After 1 hr of incubation at 37 C, loading buffer was added. The restriction digestion products were electrophoresed in a 2% agarose gel and stained with ethidium bromide. The gel was visualized by UV light.
DNA preparation for automated sequencing. The templates used in sequencing reactions were the double-stranded DNA fragments isolated from the 11 clones. The cycle sequencing reactions were consistent with the directions of the supplier of the sequencing protocol. k The sequencing reaction was prepared by using 4000-20A or 4000-28 Dye-Labeled primer. l Sequencing of all clones was done using an automated DNA sequencing kit k according to the manufacturer's instructions. A sample of the total reaction (0.1 volume) was sequenced in an automated DNA sequencer. l Sequences derived from this process were analyzed using an alignment program.
Results
DNA extracted from bison serum and 1 ovine serum sample was used in a 2-reaction nested PCR amplification. The PCR products were predicted to be 420 bp and 238 bp. The observed product of PCR amplification was a 238-bp fragment detected only in the 10 bison serum samples that were CI-ELISA positive (Fig. 1A,  1B) and not in the CI-ELISA-negative samples (Fig. 2A, 2B). CI-ELISA OHV-2-negative bison samples were PCR negative. In addition, a 238-bp fragment was detected in DNA from ovine serum (Fig. 1A) .
The amplified 238-bp fragment from each sample was transferred to a nylon membrane and hybridized with ␥-[ 32 P]-ATP 5Ј-end labeled primer 555. A single band of 238 bp was detected in the DNA samples. Hybridized fragments were observed in all samples. Representative samples 1-11, 2-15, 2-27, 2-35, 57, 112, 125 , and ovine are shown in Fig. 3 .
The PCR products of the appropriate size were cloned into the pCR2.1 vector. Resulting colonies thought to contain the appropriate insert were digested with EcoRI, and each of the cloned PCR fragments was 238 bp (Fig. 4) . Clones of each PCR product were used to prepare double-stranded DNA for use in sequencing reactions.
The nucleotide sequence of the cloned fragments was determined for all the samples. A consensus sequence was determined by comparing the sequences of all clones for each sample. The sequences were compared with the published sequence of OHV-2. 1 The homology between the nucleotide sequences obtained ranged from 82.8% to 95.4% in comparison with the OHV-2 nucleotide sequence ( Table 2 ). The homology between the nucleotide sequences from the ovine sample used in this study and the published OHV-2 sequence was 94.5% ( Table 2) .
The 238-bp sequences for the bison samples and the ovine sample were compared with each other and with the published OHV-2 sequence 1 (Fig. 5 ). Consistent nucleotide changes were found in the bison and ovine samples at positions 16, 17, 24, 26, 210, 216, 220, and 232 when compared with the OHV-2 nucleotide sequence. 1
Discussion
The application of an OHV-2-specific PCR assay has made possible detection of OHV-2 DNA in clinical cases of SA-MCF and in the implicated reservoir host, sheep. [1] [2] [3] 5, 7 In this study, PCR amplification of DNA from serum of clinically normal bison consistently produced a 238-bp fragment from each CI-ELISApositive sample. Although a 420-bp fragment has been reported to be visible with OHV-2-positive samples, only 238-bp fragments were discovered with all 11 samples. Because reduction of DNA template concentration by dilution has been reported to eliminate the larger 420-bp band, 5 diluted DNA template was used with all samples. Therefore, only the 238-bp fragments were amplified. Consistent differences of 8 nucleotides among the bison and ovine samples at positions 16, 17, 24, 26, 210, 216, 220, and 232 were detected in comparison to the OHV-2 nucleotide sequence. 1 At positions 16 (7/11), 17 (7/11), 24 (10/11), and 26 (8/11), at least 7 of the 11 sequences had a guanine instead of a cytosine. At positions 210 (10/11), 216 (11/11), 220 (10/11), and 232 (11/11), at least 10 of the 11 sequences had a cytosine instead of a guanine. These results indicate that the 2 samples are similar but not identical strains.
Considering the ability of herpesviruses to cause latent infections, it is not surprising that OHV-2 DNA was demonstrated in antibody-positive samples. Positive PCR results were obtained from sera, an indication that these animals were potentially viremic. The PCR assay does not differentiate between active and inactive virus, and stress associated with shipping and slaughter handling may hare precipitated a viremia. These findings raise the possibility that clinically normal seropositive bison can become viremic in times of stress. Cattle infected with the alphaherpesvirus bovine herpesvirus 1 can experience periodic lifelong shedding of virus. To date there are no data to show that this group of clinically normal seropositive bison shed virus; however, transmission studies in this species have not been done. Results from this study suggest that some percentage of the bison population is seropositive for OHV-2, circulates OHV-2 DNA, and represents a possible source of infection to herdmates.
